GrantExec, a Euna Solutions® company

Grants for Public housing authorities - Health

Explore 2,207 grant opportunities

Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data (R24 Clinical Trial Not Allowed)
$350,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

Jul 8, 2024

Date Added

Mar 15, 2024

The National Center for Complementary and Integrative Health (NCCIH) with the Office of Dietary Supplements (ODS) solicit limited applications for continuation of an established nuclear magnetic resonance (NMR) research resource consisting of raw and meta-data from natural products ranging from crude extracts to purified substances; with the capacity to upload, download, store, search and analyze raw NMR data. The purpose of this limited competition is to promote sustainability, scaling and wider community inclusiveness of the established NMR research resource. This notice of funding opportunity (NOFO) is part of the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. Other components of this Program include the Botanical Dietary Supplements Translational Research Teams (RM1) and Leveraging Big Data to Understand Natural Product Impacts on Whole Person Health (R01).

Health
State governments
Center of Excellence for Systems Modeling of Infection and Immunity across Biological Scales (U54 Clinical Trial Not Allowed)
$3,125,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

Jun 4, 2024

Date Added

Mar 13, 2024

The purpose of this Notice of Funding Opportunity (NOFO) is to support the establishment of one (1) Center of Excellence (CoE) to coordinate the research community of infectious and immune-mediated disease (IID) computational modelers and advance IID modeling research across biological scales. The CoE must include three (3) coordinating cores and two (2) research projects to advance and integrate bridge models across scales in the context of IID, including HIV/AIDS. The CoE will accelerate multi-scale model development, sharing and re-use, and support collaboration to benefit the entire IID research community.

Health
State governments
Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Jan 7, 2025

Date Added

Nov 29, 2021

This funding opportunity supports researchers and organizations in developing new small molecule therapies for mental and neurological disorders, focusing on innovative drug discovery methods without involving clinical trials.

Education
State governments
Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R21 Clinical Trials Not Allowed)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Mar 10, 2026

Date Added

Oct 1, 2024

This grant provides funding for early-stage research on how mitochondrial dysfunction affects aging and immune health in individuals with HIV and substance use disorders, aiming to uncover potential therapeutic strategies.

Education
State governments
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
$750,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Mar 20, 2025

Date Added

Dec 18, 2024

This funding opportunity supports research projects that develop and implement effective strategies to reduce overdose deaths and improve addiction treatment across various settings, targeting diverse populations and addressing health disparities.

Education
State governments
Pediatric HIV/AIDS Cohort Study (PHACS) (U19 Clinical Trial Not Allowed)
$5,500,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Dec 11, 2024

Date Added

Aug 19, 2024

This funding opportunity provides financial support for research focused on the long-term health outcomes of youth and young adults in the U.S. living with perinatally acquired HIV, emphasizing the impacts of antiretroviral therapy and associated health challenges.

Education
State governments
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Aug 30, 2024

Date Added

May 3, 2024

This FOA encourages applications for the Lasker Clinical Research Scholars Program for the purpose of supporting the research activities during the early stage careers of independent clinical researchers. The program offers the opportunity for a unique bridge between the NIH intramural and extramural research communities and contains two phases. In the first phase, Lasker Scholars will receive appointments for up to 5-7 years as tenure-track investigators within the NIH Intramural Research Program with independent research budgets. In the second phase, successful scholars will receive up to 3 years of NIH support for their research at an extramural research facility; or, the Scholar can be considered to remain as an investigator within the intramural program.

Education
State governments
Global Health Security to protect and improve health in Cote dIvoire with local partners
$5,000,000
U.S. Department of Health & Human Services (Centers for Disease Control-GHC)
Federal

Application Deadline

Apr 8, 2025

Date Added

Sep 10, 2024

This funding opportunity provides financial support to a variety of organizations to strengthen public health systems in Cote d'Ivoire, focusing on improving disease detection, response, and prevention capabilities.

Health
State governments
Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Mar 12, 2026

Date Added

Dec 19, 2024

This grant provides access to essential resources and expertise for researchers developing gene-based therapies for ultra-rare neurological diseases, helping them advance their projects toward regulatory approval without direct funding.

Health
State governments
Land, Health, Community in Illinois
Contact for amount
The Lumpkin Family Foundation
Private

Application Deadline

Not specified

Date Added

Jul 2, 2024

The Lumpkin Family Foundation’s **Land, Health, Community (LHC) Grant Program** serves as its core philanthropic initiative, advancing the family’s long-standing commitment to holistic community well-being in East Central Illinois. At least half of the foundation’s annual grantmaking is directed to this region, with a focus on fostering prosperity, health, leadership, and environmental stewardship. Through the LHC program, the foundation seeks to nurture communities that are economically strong, physically and mentally healthy, socially engaged, and environmentally conscious—each element reinforcing the others to create long-term resilience and vitality. A central vision of the program is to strengthen local food systems and agricultural economies while supporting residents’ physical and mental health. The foundation encourages projects that promote access to healthy, affordable food, strengthen local farm businesses, and integrate sustainable land use practices. Equally important is the cultivation of social cohesion and civic capacity—empowering communities to collaborate on shared goals, retain talent, and attract new opportunities. The emphasis on leadership development and collaborative problem-solving underscores the foundation’s belief in community-driven progress. In response to growing awareness of mental health challenges, the Lumpkin Family Foundation has expanded the LHC program to include **nature-based mental wellness initiatives**. These efforts support programs that demonstrate the connection between engagement with nature and improved mental well-being. Priority is given to projects that help youth and young adults reduce screen time through outdoor experiences, provide self-care opportunities for mental health practitioners, and create healing environments for trauma-impacted individuals such as foster youth. The foundation recognizes the strong research-based link between time spent in nature and improvements in happiness, social connectedness, and emotional balance. Successful proposals often integrate multiple LHC focus areas, combining personal health, environmental stewardship, agricultural innovation, and mental wellness. The foundation particularly values programs that promote sustainable farming, develop green practices that add productivity while protecting the land, and build community capacity through education and collaboration. Preference is given to rural organizations and those located in **Coles County** and surrounding areas, reflecting the foundation’s deep roots in East Central Illinois. Through the Land, Health, Community Grant Program, the Lumpkin Family Foundation continues to invest in the long-term vitality of its home region. By uniting efforts in agriculture, health, the environment, and mental wellness, the program fosters communities that are not only economically stable but also socially vibrant and emotionally healthy—a living model of the foundation’s belief in the interdependence of land, people, and place.

Health
Nonprofits
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)
$200,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

May 30, 2025

Date Added

Oct 28, 2024

This grant provides funding for researchers and organizations to develop innovative medical countermeasures for treating acute chemical exposures resulting from terrorist attacks or accidental releases, enhancing national preparedness for chemical emergencies.

Education
State governments
Advancing Learning Health Care Research in Outpatient Mental Health Treatment Settings (R34 Clinical Trial Optional)
$450,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 22, 2024

Date Added

Feb 9, 2024

This grant provides funding to U.S.-based educational institutions, nonprofits, and community organizations to improve mental health and substance use treatment practices in outpatient settings, particularly for underserved populations.

Education
State governments
Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)
$500,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 19, 2026

Date Added

Dec 10, 2024

This funding opportunity supports innovative research on the role of defective HIV proviruses in viral persistence and their impact on treatment strategies, targeting a wide range of eligible applicants including universities, nonprofits, and international organizations.

Food and Nutrition
State governments
Early Psychosis Intervention Network (EPINET): Learning Health Care Research to Improve Mental Health Services and Outcomes (P01 Clinical Trial Optional)
$1,000,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 3, 2025

Date Added

Sep 24, 2024

This grant provides funding for research projects that improve mental health services and outcomes for young people experiencing early stages of psychosis by promoting data-driven care and collaboration among specialized treatment programs across the United States.

Health
State governments
Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 18, 2024

Date Added

Jul 15, 2024

This funding opportunity provides financial support for organizations to archive and document child health and human development data sets, facilitating their accessibility for secondary analysis by researchers.

Health
State governments
Advancing Translation of Long-Acting Strategies for HIV and HIV-Associated Co-infections (AT LASt) (R61/R33 Clinical Trial Not Allowed)
$700,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Mar 13, 2025

Date Added

Nov 25, 2024

This funding opportunity provides financial support for researchers and organizations developing innovative long-acting treatments for HIV and related co-infections, aiming to improve patient adherence and health outcomes.

Health
State governments
Bat Immunology Network Research Resource Program (U24 Clinical Trial Not Allowed)
$350,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

May 24, 2024

Date Added

Dec 13, 2023

The purpose of this Notice of Funding Opportunity (NOFO) is to support the development and validation of reagents/tools to support research to characterize cellular and molecular constituents of the bat immune system and for the study of protective innate and adaptive immune mechanisms in bats. The Research Resource Program established by this NOFO will participate within a collaborative research network to advance understanding of the bat immune response. This NOFO will support the establishment and operation of a Bat Immunology Research Resource Program for the development and validation of reagents/tools for use in immunological studies using the bat model system. The recipient will participate in the Bat Immunology Network, which will consist of the Research Resource Program, the research projects supported by RFA-AI-23-068, and possible other participants as determined by NIAID. The Research Resource Program will conduct reagent/tool development and validation using appropriate systems, which includes testing against multiple bat species. While other members of the Bat Immunology Network may assist in validation efforts, reagent/tool validation is the responsibility of the Research Resource Program. Reagents/tools developed by the Research Resource Program will be provided to the research projects of the Bat Immunology Network. Reagents/tools will be made available to the broader research community through technology transfer arrangements, deposition to nonprofit repositories, and/or timely transfer to industry for commercialization. Areas of high priority include, but are not limited to, the development and validation of the following: Soluble immune molecules (e.g., cytokines, chemokines) for use in tissue culture or in vivo animal studies Antibodies or other probes/detection markers for use in cellular phenotyping, functional studies and/or immunoassays

Health
State governments
Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed)
$200,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Sep 7, 2025

Date Added

Sep 20, 2023

This funding opportunity supports innovative research aimed at developing new strategies for curing HIV at the start of antiretroviral therapy, targeting researchers and institutions focused on reducing the HIV reservoir and improving immune responses.

Health
State governments
Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional)
$750,000
HHS-AHRQ (Agency for Health Care Research and Quality)
Federal

Application Deadline

Jul 17, 2024

Date Added

Feb 9, 2021

This FOA invites applications that propose research projects that test promising digital healthcare interventions aimed at improving quality of care and healthcare services delivery at the point of care. This FOA will use the Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities, and up to 3 years of R33 support for expanded activities.The Agency for Healthcare Research and Quality's (AHRQ) mission is to produce evidence to make health care safer, of higher quality, more accessible, equitable, and affordable, and to work within the U.S. Department of Health and Human Services and with other partners to make sure that the evidence is understood and used. This FOA invites applications that propose research projects that test promising digital healthcare interventions aimed at improving quality of care and healthcare services delivery at the point of care. This FOA will use the Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities, and up to 3 years of R33 support for expanded activities. Transition to the R33 phase is not guaranteed for all grants awarded under this FOA. Continuation from the R21 phase to the R33 phase will be determined by AHRQ staff based on progress achieved in the R21 phase and factors such as program priorities and availability of funds.

Health
State governments
NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Sep 7, 2024

Date Added

Jun 28, 2021

The National Eye Institute (NEI) supports investigator-initiated, complex, multi-center and other high resource risk epidemiologic studies under the cooperative agreement mechanism, UG1 activity code. Specifically, the purpose of this Funding Opportunity Announcement (FOA) is to support new and innovative ocular epidemiology research.The purpose of this Funding Opportunity Announcement (FOA) is to support epidemiologic studies that utilize creative and innovative approaches to studying vision diseases and disorders with high public impact and whose findings will inform prevention and treatment strategies as well as basic sciences research. Background: Clinical vision research projects, including epidemiologic studies, are part of NEI’s core strategy for improving visual health and decreasing visual impairment in populations through research on the burden of disease, its causes, diagnosis, prevention, treatment and rehabilitation. Projects should focus on NEI’s mission to protect and improve visual health including, but not limited to: Determining the burden of eye diseases and their visual outcomes in a changing population, particularly disparities in the burden and the influences of sociocultural, environmental, economic, and demographic factors. Improving early diagnosis of ocular diseases and their underlying processes through new screening and detection strategies. Determining risk factors for ocular diseases. Identifying and assessing strategies that will overcome barriers to eye care and convert evidence-based findings into improved patient and population outcomes. Studying the interplay of factors that exacerbate or mitigate risk for eye diseases. The NEI encourages applications to support ocular epidemiologic research. These projects are supported under the cooperative agreement mechanism. Applicants are strongly encouraged to contact Scientific/Research staff as plans for an application are being developed (see Section VII, Agency Contacts), preferably no later than 12 weeks prior to the anticipated application submission date.

Health
State governments